Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

STA 5326

Known as: STA-5326, STA5326 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Apilimodapilimod mesylate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer
The Interleukin-23 (IL-23)/IL-23R signaling axis is an important inflammatory pathway, involved in the stimulation and regulation… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2011
Review
2011
New Interleukin-23 Pathway Inhibitors in Dermatology
Interleukin (IL)-23 is an important regulator of T helper-17 lymphocytes, which influence the cutaneous immune system by… Expand
Is this relevant?
Review
2010
Review
2010
[Therapeutic effect of the low molecular weight inhibitor of the NF-kappaB signaling pathway on experimental autoimmune uveoretinitis].
  • H. Keino
  • Nippon Ganka Gakkai zasshi
  • 2010
    • Corpus ID: 25554608
The nuclear factor-kappaB (NF-kappaB) proteins are a family of ubiquitously expressed transcriptional proteins in most immune and… Expand
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Randomized, double‐blind, placebo‐controlled trial of the oral interleukin‐12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease
Background: Interleukin‐12 (IL‐12) and interleukin‐23 (IL‐23) are inflammatory cytokines linked to the Th‐1 and Th‐17 phenotypes… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2008
2008
Therapeutic effect of the potent IL-12/IL-23 inhibitor STA-5326 on experimental autoimmune uveoretinitis
IntroductionThe purpose of this study was to determine if oral administration of the interleukin (IL) 12/IL-23 inhibitor, STA… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2008
2008
Therapeutic Effect of the IL-12/IL-23 Inhibitor STA5326 in Experimental Autoimmune Uveoretinitis
 
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor.
The interleukin-12 (IL-12) cytokine induces the differentiation of naive T cells to the T helper cell type 1 (Th1) phenotype and… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
STA5326 is a well-tolerated and effective treatment for active Crohn's disease
  • Nature Clinical Practice Gastroenterology…
  • 2006
    • Corpus ID: 41530520
An Australian team has shown that fecal levels of S100A12—a calcium-binding protein found at high concentrations in the serum of… Expand
Is this relevant?
Highly Cited
2006
Highly Cited
2006
A phase 1/2A Trial of STA 5326, an oral interleukin‐12/23 inhibitor, in patients with active moderate to severe Crohn's disease
Background: Intestinal inflammation associated with Crohn's disease is characterized by a type 1 helper T cell response and… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE